Medical supplies contracts in Germany

1,508 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance FAM OLIMEL (excluding electrolyte-free; 7, 6 %; KPG) + interchangeable FAM, ATC B05BA10 for the period 1.10.26-30.09.28

DAK-Gesundheit, HamburgTED 572069-2026

€11 lot, 2 years

Sat 5 Aug12:00 in Berlin

646days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Dapagliflozin, ATC A10BK01, for the period from 01.10.2026 to 30.09.2028

DAK-Gesundheit, HamburgTED 571195-2026

€11 lot, 2 years

Sat 5 Aug12:00 in Berlin

646days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Rifaximin, ATC A07AA11, for the period 01.10.2026 - 30.09.2028

DAK-Gesundheit, HamburgTED 569831-2026

€11 lot, 2 years

Sat 5 Aug12:00 in Berlin

646days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Grass Pollen Extract (Timothy, Rye, etc.), ATC code V01AA02, for the period 01.10.2026 - 30.09.2028

DAK-Gesundheit, HamburgTED 571079-2026

€11 lot, 2 years

Sat 5 Aug12:00 in Berlin

646days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance FAM CERNEVIT (excluding KPG) and interchangeable FAM, ATC B05XC30, for the period 01.10.2026 - 30.09.2028

DAK-Gesundheit, HamburgTED 570900-2026

€11 lot, 2 years

Sat 5 Aug12:00 in Berlin

646days

Conclusion of a non-exclusive discount agreement under § 130a paragraph 8 of the German Social Security Code (SGB V) for the active substance Faricimab, ATC code S01LA09, for the period from 01.10.2026 to 30.09.2028

DAK-Gesundheit, HamburgTED 571028-2026

€11 lot, 2 years

Sat 5 Aug12:00 in Berlin

646days

Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 of the Fifth Book of the German Social Code (SGB V) on various active substances and/or combinations thereof, with possibility of conclusion at any time within the so-called Open House procedure

AOK Nordost. Die Gesundheitskasse., PotsdamTED 512015-2026

value not stated18 lots

Sat 5 Aug23:58 in Berlin

646days

Conclusion of non-exclusive discount agreements under § 130a Abs. 8 SGB V for various active substance(s)/combinations with the possibility of concluding at any time within the so-called Open House procedure

AOK Nordost. Die Gesundheitskasse., PotsdamTED 622246-2026

value not stated3 lots

Sat 5 Aug23:58 in Berlin

646days

Open Framework Agreement on Drug Discounts under § 130a Abs. 8 SGB V with the possibility of joining at any time, so-called Admission Model 2026-10

Deutsche Rentenversicherung Knappschaft-Bahn-See, BochumTED 590561-2026

value not stated32 lots

Sat 5 Aug23:59 in Berlin

646days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for medicinal products containing the active substance Cefuroxime in parenteral dosage form, authorised for prescription and supply within the scope of outpatient care in Lower Saxony (ATC Code: J01DC02).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 633955-2026

value not stated1 lot

Sun 27 Aug12:00 in Berlin

668days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for medicinal products containing the active substance Bexarotene (ATC Code: L01XF03).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 632738-2026

value not stated1 lot

Sun 27 Aug12:00 in Berlin

668days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for medicinal products containing the active substance Prednisolone, excluding tablets in packages larger than 50 units, authorised for prescription and supply within the scope of outpatient care in Lower Saxony (WHO ATC Code: H02AB06).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 635633-2026

value not stated1 lot

Sun 27 Aug12:00 in Berlin

668days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicinal products with the active substance Colchicine (ATC-Code: M04AC01).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 636924-2026

value not stated1 lot

Mon 28 Aug12:00 in Berlin

669days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicinal products with the active substance Goserelin (ATC-Code: L02AE03).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 634164-2026

value not stated1 lot

Mon 28 Aug12:00 in Berlin

669days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for medicinal products containing the active substance paliperidon, excluding depot injection suspensions for monthly dosing (ATC Code: N05AX13).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 638261-2026

value not stated1 lot

Mon 28 Aug12:00 in Berlin

669days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines containing the active substance Pirdinol (ATC-code: M03BX03).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 628335-2026

value not stated1 lot

Mon 28 Aug12:00 in Berlin

669days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines containing the active substance Adalimumab (ATC-code: L04AB04).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 628526-2026

value not stated1 lot

Mon 28 Aug12:00 in Berlin

669days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicinal products with the active substance Perampanel (ATC-Code: N03AX22).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 636274-2026

value not stated1 lot

Mon 28 Aug12:00 in Berlin

669days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicinal products with the active substance Trastuzumab, excluding compounding (ATC-Code: L01FD01).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 637587-2026

value not stated1 lot

Mon 28 Aug12:00 in Berlin

669days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines containing the active substance combination of Drospirenone and Ethinylestradiol (ATC-code: G03AA12).

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 626419-2026

value not stated1 lot

Mon 28 Aug12:00 in Berlin

669days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.